- Home
- OLMA vs NX Comparison
OLMA vs NX Comparison
Compare OLMA & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OLMA
- NX
- Stock Information
- Founded
- OLMA 2006
- NX 1927
- Country
- OLMA United States
- NX United States
- Employees
- OLMA N/A
- NX N/A
- Industry
- OLMA Biotechnology: Pharmaceutical Preparations
- NX Metal Fabrications
- Sector
- OLMA Health Care
- NX Industrials
- Exchange
- OLMA Nasdaq
- NX Nasdaq
- Market Cap
- OLMA 725.5M
- NX 660.6M
- IPO Year
- OLMA 2020
- NX N/A
- Fundamental
- Price
- OLMA $8.72
- NX $14.90
- Analyst Decision
- OLMA Strong Buy
- NX
- Analyst Count
- OLMA 6
- NX 0
- Target Price
- OLMA $23.00
- NX N/A
- AVG Volume (30 Days)
- OLMA 1.5M
- NX 558.8K
- Earning Date
- OLMA 11-07-2025
- NX 12-11-2025
- Dividend Yield
- OLMA N/A
- NX 2.12%
- EPS Growth
- OLMA N/A
- NX N/A
- EPS
- OLMA N/A
- NX N/A
- Revenue
- OLMA N/A
- NX $1,839,956,000.00
- Revenue This Year
- OLMA N/A
- NX $46.73
- Revenue Next Year
- OLMA N/A
- NX $0.48
- P/E Ratio
- OLMA N/A
- NX N/A
- Revenue Growth
- OLMA N/A
- NX 70.18
- 52 Week Low
- OLMA $2.86
- NX $13.11
- 52 Week High
- OLMA $13.51
- NX $32.23
- Technical
- Relative Strength Index (RSI)
- OLMA 47.84
- NX 46.69
- Support Level
- OLMA $7.80
- NX $13.99
- Resistance Level
- OLMA $8.48
- NX $15.83
- Average True Range (ATR)
- OLMA 0.76
- NX 0.57
- MACD
- OLMA -0.31
- NX 0.26
- Stochastic Oscillator
- OLMA 44.15
- NX 65.81
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
About NX Quanex Building Products Corporation
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.